Phase 2 Study of Relmacabtagene Autoleucel (CD19 CAR-T) for Relapsed/Refractory Mantle Cell Lymphoma in Chinese Adults.
Xie Y, Zhou K, Li L, Liang A, Mei H, Zou D, Li W, Jin J, Jin Z, Jing HM, Yang H, Chen T, Huang H, He P, Cao J, Zhu J, Song Y, Xia Z, Gu YE, Zang Y, Zhou Z, Tian ZZ.
Xie Y, et al. Among authors: huang h.
Blood Adv. 2025 Aug 14:bloodadvances.2024015763. doi: 10.1182/bloodadvances.2024015763. Online ahead of print.
Blood Adv. 2025.
PMID: 40811825